Oda H - Search Results

1

Erk pathways negatively regulate matrix mineralization.

Kono SJ, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K, Kawaguchi H, Tanaka S. Kono SJ, et al. Among authors: oda h. Bone. 2007 Jan;40(1):68-74. doi: 10.1016/j.bone.2006.07.024. Epub 2006 Sep 15. Bone. 2007. PMID: 16978937

2

Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.

Yamamoto A, Miyazaki T, Kadono Y, Takayanagi H, Miura T, Nishina H, Katada T, Wakabayashi K, Oda H, Nakamura K, Tanaka S. Yamamoto A, et al. Among authors: oda h. J Bone Miner Res. 2002 Apr;17(4):612-21. doi: 10.1359/jbmr.2002.17.4.612. J Bone Miner Res. 2002. PMID: 11918218 Free article.

3

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.

Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. Takayanagi H, et al. Among authors: oda h. Nature. 2002 Apr 18;416(6882):744-9. doi: 10.1038/416744a. Nature. 2002. PMID: 11961557

4

IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex.

Nakamura I, Kadono Y, Takayanagi H, Jimi E, Miyazaki T, Oda H, Nakamura K, Tanaka S, Rodan GA, Duong LT. Nakamura I, et al. Among authors: oda h. J Immunol. 2002 May 15;168(10):5103-9. doi: 10.4049/jimmunol.168.10.5103. J Immunol. 2002. PMID: 11994463

5

A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders.

Juji T, Hertz M, Aoki K, Horie D, Ohya K, Gautam A, Mouritsen S, Oda H, Nakamura K, Tanaka S. Juji T, et al. Among authors: oda h. J Bone Miner Metab. 2002;20(5):266-8. doi: 10.1007/s007740200038. J Bone Miner Metab. 2002. PMID: 12203031 Review. No abstract available.

6

[A case of SAPHO syndrome with paraplegia due to a thoracic kyphosis].

Fujii T, Matsudaira K, Oda H, Seichi A, Nakamura K. Fujii T, et al. Among authors: oda h. Ryumachi. 2002 Aug;42(4):687-93. Ryumachi. 2002. PMID: 12355864 Japanese.

7

Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.

Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H. Kawaida R, et al. Among authors: oda h. J Exp Med. 2003 Apr 21;197(8):1029-35. doi: 10.1084/jem.20021321. J Exp Med. 2003. PMID: 12707301 Free PMC article.

8

Signal transduction pathways regulating osteoclast differentiation and function.

Tanaka S, Nakamura I, Inoue J, Oda H, Nakamura K. Tanaka S, et al. Among authors: oda h. J Bone Miner Metab. 2003;21(3):123-33. doi: 10.1007/s007740300021. J Bone Miner Metab. 2003. PMID: 12720046 Review. No abstract available.

9

Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.

Yamamoto A, Fukuda A, Seto H, Miyazaki T, Kadono Y, Sawada Y, Nakamura I, Katagiri H, Asano T, Tanaka Y, Oda H, Nakamura K, Tanaka S. Yamamoto A, et al. Among authors: oda h. Arthritis Rheum. 2003 Sep;48(9):2682-92. doi: 10.1002/art.11214. Arthritis Rheum. 2003. PMID: 13130489 Free article.

10

Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim.

Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S. Akiyama T, et al. Among authors: oda h. EMBO J. 2003 Dec 15;22(24):6653-64. doi: 10.1093/emboj/cdg635. EMBO J. 2003. PMID: 14657036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,365 results

Search Page

Filters